3-hydroxybutyric acid has been researched along with Ovarian Neoplasms in 3 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In women with ovarian or endometrial cancer, a KD results in selective loss of fat mass and retention of lean mass." | 2.87 | A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer. ( Alvarez, RD; Arend, RC; Bevis, KS; Cohen, CW; Fontaine, KR; Gower, BA; Huh, WK; Kim, KH; Leath, CA; Straughn, JM, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Scalise, CB | 1 |
| Norian, L | 1 |
| Demark-Wahnefried, W | 1 |
| Ghahremani, H | 1 |
| Nabati, S | 1 |
| Tahmori, H | 1 |
| Peirouvi, T | 1 |
| Sirati-Sabet, M | 1 |
| Salami, S | 1 |
| Cohen, CW | 1 |
| Fontaine, KR | 1 |
| Arend, RC | 1 |
| Alvarez, RD | 1 |
| Leath, CA | 1 |
| Huh, WK | 1 |
| Bevis, KS | 1 |
| Kim, KH | 1 |
| Straughn, JM | 1 |
| Gower, BA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Targeted Disruption to Cancer Metabolism Through Dietary Macronutrient Modification[NCT03171506] | 57 participants (Actual) | Interventional | 2015-11-09 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for 3-hydroxybutyric acid and Ovarian Neoplasms
| Article | Year |
|---|---|
A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer.
Topics: 3-Hydroxybutyric Acid; Body Composition; Body Fluid Compartments; Diet, Ketogenic; Endometrial Neopl | 2018 |
2 other studies available for 3-hydroxybutyric acid and Ovarian Neoplasms
| Article | Year |
|---|---|
Long-Term Glucose Restriction with or without Beta-Hydroxybutyrate Enrichment Distinctively Alters Epithelial-Mesenchymal Transition-Related Signaling in Ovarian Cancer Cells.
Topics: 3-Hydroxybutyric Acid; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Epithelial-Me | 2022 |
Long-Term Glucose Restriction with or without β-Hydroxybutyrate Enrichment Distinctively Alters Epithelial-Mesenchymal Transition-Related Signalings in Ovarian Cancer Cells.
Topics: 3-Hydroxybutyric Acid; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Female; G | 2021 |